80 William Street
14 articles with Lumicell
Lumicell Completes Enrollment of Phase C Feasibility Trial for Breast Cancer Surgical Guidance Solution
Lumicell, Inc., an innovation leader in image guided cancer surgery, today announced that it has completed enrollment in its Phase C feasibility clinical trial of the Lumicell Imaging System for breast cancer
Feasibility Study Underway to Assess Lumicell Technology for Removing Ovarian and Peritoneal Cancer Tumors During the First Surgery
Positive Clinical Results in Breast Cancer Trial Shows Promise for Ovarian and Other Cancers
New location offers more space for future expansions and is designed to inspire innovation of Lumicell technology through further employee collaboration
Hershberger brings over 25 years of global financial management experience from a variety of life science products and manufacturing companies
Industry executive with history of building successful Boston-based businesses will serve as an advisor to the development of Lumicell’s growth and long-term business strategies
New business unit aims to tackle challenges around chronic wounds
Members will serve as key advisors and foundational partners in the development of Lumicell technology
Lumicell Presents Phase II Clinical Data Showing LUM System Provided Complete and Immediate Detection of Residual Cancer in Tumor Cavity During Lumpectomy Surgery
The Phase 2 data were presented at the 2017 San Antonio Breast Cancer Symposium (SABCS) being held December 5-9, 2017 in San Antonio, Texas.
Existing and new investors, including Launch Capital and BlueIO participated in the financing.
Lumicell Initiates New Clinical Studies In Breast Cancer And Prostate Cancer With LUM System For Real-Time Detection Of Tumor Tissue In Patients During Surgery